EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Therapeutic Nanozymes in Rheumatoid Arthritis Treatment Through Disease Stage-Oriented Strategies

Ye Zhou, Heguo Yan, Fanyu Meng, Hengyan Zhang, Xingyu Tao, Yue Zhang, Jiaming Li, Yulian Yang, Kuncai Liu, Jiangyun Peng, Zining Peng iD

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s574600 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Ye Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, People's Republic of China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Nanostructures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) progresses through distinct pathophysiological states, transitioning from acute inflammatory phases with largely reversible tissue damage to chronic destructive stages characterized by irreversible structural alterations. Current therapeutic approaches largely employ uniform interventions without accounting for this disease heterogeneity, potentially compromising treatment efficacy. Dysregulated reactive oxygen species metabolism represents a mechanistic thread connecting RA stages. Acute inflammation is characterized by intense oxidative bursts, whereas chronic RA exhibits persistent oxidative stress, establishing a stage-dependent rationale for enzyme-based intervention. However, natural antioxidant enzymes are rapidly inactivated within the harsh inflammatory microenvironment, which is defined by acidic conditions and elevated proteolytic activity. Nanozymes are nanomaterials with enzyme-like catalytic activities, which overcome these limitations through enhanced environmental stability, tunable catalytic activity, and multifunctional integration. In contrast to prior nanozyme reviews that primarily organized discussions by material types or catalytic mechanisms, this review adopts a stage-oriented framework that aligns therapeutic strategies with the temporal evolution of RA pathophysiology. During acute inflammatory phases, nanozyme platforms integrate catalytic performance optimization, targeted delivery mechanisms, and synergistic anti-inflammatory interventions to rapidly neutralize oxidative stress and disrupt inflammatory cascades before irreversible damage occurs. In chronic destructive phases, therapeutic approaches combine sustained catalytic activity, precision targeting of established pathological structures, and multifunctional integration to concurrently suppress residual inflammation and promote tissue regeneration. This review compares nanozyme therapeutics with established RA treatments, including disease-modifying antirheumatic drugs and biological agents, to clarify their potential clinical positioning. Key challenges for clinical translation include long-term safety characterization; pharmacokinetic evaluation, particularly for intra-articular delivery; regulatory pathway development; and manufacturing scalability. Overall, this review establishes a stage-oriented nanozyme therapeutic framework aligned with RA progression patterns and provides translational guidance for developing nanozyme therapeutics tailored to individual pathological characteristics in RA management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidNanostructuresHumansAnimalsOxidative StressReactive Oxygen SpeciesAnti-Inflammatory AgentsNanomedicineAntioxidants

Stichwörter der Autor:innen

Rheumatoid arthritiscatalytic nanomaterialsnanozymesprecision medicinereactive oxygen species

Substanzen

Reactive Oxygen SpeciesAnti-Inflammatory AgentsAntioxidants

Autor:innen und Institutionen

  • First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, People's Republic of China.
  • Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, People's Republic of China.
  • Department of Rheumatology, Zhaotong Hospital of Traditional Chinese Medicine, Zhaotong, People's Republic of China.
  • Department of Rheumatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, People's Republic of China.

ORCID-Profile: Zining Peng

Zitieren

APA

Zhou, Y., Yan, H., Meng, F., Zhang, H., Tao, X., Zhang, Y., Li, J., Yang, Y., Liu, K., Peng, J., & Peng, Z. (2026). Therapeutic Nanozymes in Rheumatoid Arthritis Treatment Through Disease Stage-Oriented Strategies. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s574600

Vancouver

Zhou Y, Yan H, Meng F, Zhang H, Tao X, Zhang Y, et al. Therapeutic Nanozymes in Rheumatoid Arthritis Treatment Through Disease Stage-Oriented Strategies. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s574600

BibTeX
@article{Zhou2026,
  author = {Zhou, Ye and Yan, Heguo and Meng, Fanyu and Zhang, Hengyan and Tao, Xingyu and Zhang, Yue and Li, Jiaming and Yang, Yulian and Liu, Kuncai and Peng, Jiangyun and Peng, Zining},
  title = {Therapeutic Nanozymes in Rheumatoid Arthritis Treatment Through Disease Stage-Oriented Strategies},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s574600}
}
Kostenlos starten →